Manage opioid addiction with medication support

QuickMD offers Medication for Opioid Use Disorder (MOUD) in most states. Please check our service map for availability in your state.

All appointments for addiction treatment are $99. Your initial appointment includes one follow-up appointment at no extra cost as long as it’s completed within 14 days of your first appointment. Medication costs are not included and may vary based on the pharmacy you choose and your prescription drug coverage.

Your first appointment is called the induction appointment. During this appointment, your provider will prescribe a 7-day supply of buprenorphine-naloxone (Suboxone®) to monitor your tolerance and adjust the dosage as needed.

After induction, you’ll continue with monthly follow-up visits as part of your ongoing treatment plan.

To help ensure continuous care and avoid interruptions in your treatment, we recommend scheduling your follow-up appointment at least one week after your induction appointment or before your initial prescription ends.

Your follow-up appointment must be scheduled within 14 days of your induction appointment to remain covered by the initial $99 rate. After this 14-day window, additional fees may apply. If the follow-up isn’t completed within this timeframe, it will no longer be covered under the induction package, and a $99 fee will apply. For patients who miss their follow-up, they will receive a $64 credit toward a future appointment. Refunds are not available.

This bundled induction pricing is only available to new addiction treatment patients and does not extend to patients re-initiating a new induction treatment.

QuickMD offers Medication for Opioid Use Disorder (MOUD) in most states. Please check our service map to confirm availability in your state. We are proud to be the largest TeleMOUD provider in the U.S., serving a broad and growing network of patients across the nation.

To receive care, patients must:

• Be 18 years or older
• Be physically located in the state that issued their valid photo ID at the time of the appointment

Please note:

• We are unable to send prescriptions across state lines, even if you’re located near a border.
• Suboxone® cannot be prescribed while you are traveling in a different state.
• Patients cannot change their address more than 1 time in a 6 month period.

If you accidentally schedule an appointment in the wrong state, our Patient Support team may reschedule your appointment with a provider licensed in your applicable state for an administrative fee of $35.

QuickMD offers fully remote addiction treatment. Our licensed providers can initiate and manage treatment, including prescribing buprenorphine-naloxone (Suboxone®), without the need for an initial in-person visit. However, some states require annual or semi-annual in-person visits to maintain telemedicine-based addiction treatment. Please visit our in-person clinics page for more information about state requirements.

QuickMD providers primarily prescribe Suboxone® (buprenorphine-naloxone) in accordance with U.S. Drug Enforcement Administration (DEA) regulations and current clinical best practices, as Subutex (buprenorphine only) carries a higher risk potential for misuse.

However, in cases where a patient has a documented allergy or adverse reaction to Suboxone®, an alternative such as Subutex may be offered. For further information, please contact us directly.

Due to federal regulations governing Medication for Opioid Use Disorder (MOUD), early refills of Suboxone® are not permitted. These guidelines, enforced by the U.S. Drug Enforcement Administration (DEA), are designed to ensure safe, consistent use and apply to both patients and providers.

We recommend scheduling your next appointment several days before your current supply runs out to avoid delays or pharmacy-related issues. While individual pharmacies may offer a grace period of 1–3 days, QuickMD cannot authorize refills outside of a pharmacy’s grace period. 

Early refills cannot be approved in the following situations:

• Lost or stolen medication
• Taking more than the prescribed dosage
• Travel-related early refills

If you anticipate travel, please inform your provider in advance. In some cases, they may issue a shorter prescription to ensure your refill date aligns with your travel plans.

For additional questions or personalized guidance, please contact us directly.

While Suboxone® (buprenorphine-naloxone) is FDA-approved for the treatment of opioid use disorder, it has also shown clinical effectiveness in managing dependence and withdrawal symptoms related to substances like Tianeptine and Kratom, due to their activity at mu-opioid receptors.

Tianeptine, though not classified as a traditional opioid, acts as a mu-opioid receptor agonist, producing effects and withdrawal symptoms similar to those seen in opioid use disorder. According to an article in the Journal of Addiction Medicine, “Chronic daily use of tianeptine may represent tianeptine use disorder, which can have a clinical course consistent with opioid use disorder, including the development of impaired control, functional impairment, tolerance, and withdrawal. It is appropriate to consider medications (like buprenorphine) for opioid use disorder, for the management of tianeptine use disorder.”

Similarly, Kratom contains mitragynine, which also activates mu-opioid receptors. Cases of Kratom dependence, withdrawal, and addiction have been successfully managed using buprenorphine-based therapy.

At QuickMD, our providers use established MOUD protocols to treat Kratom and Tianeptine addiction in appropriate cases, based on clinical judgment and the patient’s individual needs.